STOK
Stoke Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$28.17-3.03%
Price as of Jul 20, 2026
STOK ownership
Stoke Therapeutics, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$408.1K
Insider trades by month Buys Sells
Dec
Mar
Apr
May
Jun
Jul
Context3-month price -20.3%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | McCauley Thomasofficer: Chief Scientific Officer | Grant | 225,000 | $29.91 |
| Jul 6, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 500 | $33.27 |
| Jul 6, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 6,728 | $32.62 |
| Jun 18, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 1,457 | $29.95 |
| Jun 5, 2026 | Kaye Edward M. MDdirector | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | Burstein Jenniferdirector | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | Smith Juliedirector | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | TZIANABOS ARTHURdirector | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | LEVIN ARTHUR Adirector | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | Krainer Adrian R.director | Grant | 17,786 | $29.46 |
| Jun 5, 2026 | Harrison Seth Loringdirector | Grant | 17,786 | $29.46 |
| Jun 3, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 1,795 | $30.58 |
| May 5, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 2,243 | $32.79 |
| Apr 7, 2026 | Kahn Claredirector | Grant | 30,782 | $32.79 |
| Apr 3, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 1,838 | $32.66 |
| Mar 24, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 601 | $34.41 |
| Mar 24, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 8,692 | $33.64 |
| Mar 19, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 483 | $31.79 |
| Mar 19, 2026 | Leggett Thomasofficer: Chief Financial Officer | Sell | 2,173 | $31.28 |
| Mar 19, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 72 | $32.85 |
| Mar 19, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 2,476 | $32.74 |
| Mar 19, 2026 | Hoitt Jasonofficer: Chief Patient Officer | Sell | 1,033 | $32.74 |
| Mar 19, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 103 | $32.85 |
| Mar 19, 2026 | Hoitt Jasonofficer: Chief Patient Officer | Sell | 30 | $32.85 |
| Mar 19, 2026 | Hoitt Jasonofficer: Chief Patient Officer | Sell | 139 | $31.79 |
| Mar 19, 2026 | Leggett Thomasofficer: Chief Financial Officer | Sell | 172 | $31.79 |
| Mar 19, 2026 | Allan Jonathanofficer: GENERAL COUNSEL & CORP SEC | Sell | 334 | $31.79 |
| Mar 19, 2026 | Hoitt Jasonofficer: Chief Patient Officer | Sell | 748 | $33.38 |
| Mar 19, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 6,100 | $31.28 |
| Mar 19, 2026 | Ticho Barryofficer: CHIEF MEDICAL OFFICER | Sell | 1,461 | $29.99 |
Source: STOK SEC Form 4 filings, latest Jul 17, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their STOK positions over the last 6 months (SEC Form 13F).
Increased
144
New positions
82
Reduced
114
Sold out
45
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| RTW INVESTMENTS, LP | Increased | 5.6M | May 15, 2026 |
| FMR LLC | Reduced | 5.6M | Feb 17, 2026 |
| RTW INVESTMENTS, LP | Increased | 5.5M | Feb 17, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Unchanged | 5.4M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 5.4M | May 13, 2026 |
| FMR LLC | Reduced | 5.4M | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 5.2M | Feb 12, 2026 |
| LYNX1 CAPITAL MANAGEMENT LP | Reduced | 4.8M | May 4, 2026 |
| REDMILE GROUP, LLC | Increased | 4.2M | May 15, 2026 |
| REDMILE GROUP, LLC | Reduced | 4.0M | Feb 17, 2026 |
| MORGAN STANLEY | Increased | 3.5M | Feb 13, 2026 |
| MORGAN STANLEY | Reduced | 3.4M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 3.3M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Reduced | 3.3M | Feb 17, 2026 |
| TORONTO DOMINION BANK | Unchanged | 3.2M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.